Skip to main content
Kindstar Globalgene Technology, Inc. logo

Kindstar Globalgene Technology, Inc. — Investor Relations & Filings

Ticker · 9960 ISIN · KYG5262E1044 HKEX Human health and social work activities
Open in API
Filings indexed 602 across all filing types
Latest filing 2026-01-07 M&A Activity
Country HK Hong Kong
Listing HKEX 9960

About Kindstar Globalgene Technology, Inc.

http://www.kindstar.com.cn

Kindstar Globalgene Technology, Inc. is a leading independent provider of advanced specialty clinical testing services, specializing in esoteric testing. The company maintains the largest esoteric testing portfolio in its market, utilizing internationally-advanced laboratory facilities for clinical testing, scientific research, and applied R&D. Its comprehensive testing menu, featuring over 100 items, covers critical diagnostic areas including hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology. These services provide physicians and patients access to specialized diagnostics crucial for the diagnosis and treatment of major diseases.

Recent filings

Filing Released Lang Actions
SUPPLEMENTAL ANNOUNCEMENT TO CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF 40% EQUITY INTEREST IN HUAXI KINDSTAR
M&A Activity Classification · 95% confidence The document is a 'Supplemental Announcement' regarding a previously disclosed connected transaction (acquisition of 40% equity interest in Huaxi Kindstar). It provides detailed valuation assumptions, including revenue growth projections, cost structures, gross profit margins, capital expenditure plans, and the methodology for calculating the discount rate (WACC/CAPM). This type of detailed disclosure regarding the financial valuation of a transaction is a standard component of M&A-related regulatory filings, specifically falling under the category of M&A Activity (TAR) as it provides the financial justification and valuation details for a takeover/acquisition bid.
2026-01-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025
Share Issue/Capital Change Classification · 100% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for listed companies to report monthly movements in their securities, including changes in issued shares, treasury shares, and share options. Since it details changes in capital structure and share issuance, it falls under the category of Share Issue/Capital Change.
2026-01-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025
Share Issue/Capital Change Classification · 100% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for listed companies in Hong Kong to report monthly movements in their securities, including share capital, treasury shares, and share options. Since it details changes in share capital and securities, it falls under the category of share issues and capital changes.
2025-12-04 English
CONNECTED TRANSACTION - ACQUISITION OF 40% EQUITY INTEREST IN HUAXI KINDSTAR
M&A Activity Classification · 100% confidence The document is an official announcement regarding a 'Connected Transaction' involving the acquisition of a 40% equity interest in a subsidiary (Huaxi Kindstar). It details the transaction terms, valuation, listing rule implications, and strategic rationale. This type of document is a standard regulatory disclosure for M&A or asset acquisition activity under the Hong Kong Stock Exchange Listing Rules, which falls under the 'M&A Activity' category.
2025-11-25 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025
Regulatory Filings Classification · 85% confidence The document is an HKEX Form FF301 “Monthly Return for Equity Issuer and Hong Kong Depositary Receipts” showing detailed movements in share capital, issued shares, treasury shares, option schemes, etc. It is a periodic regulatory return under Chapter 19B of the Exchange Listing Rules, rather than an annual or interim report, earnings release, or capital financing update. It does not announce or summarize a forthcoming report but constitutes the full regulatory filing itself. It thus falls under the general “Regulatory Filings” fallback category (RNS).
2025-11-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025
Regulatory Filings Classification · 85% confidence The document is a standard HKEX Listing Rule monthly return (Form FF301) detailing movements in authorized share capital, issued shares, share options, and related securities for the month ended 30 September 2025. It is a routine compliance filing under Chapter 19B of the Exchange Listing Rules, not an earnings release, board change, capital raise announcement, or annual/interim report. It does not announce a specific transaction but provides the required periodic regulatory disclosure. Therefore, it falls into the fallback category of Regulatory Filings.
2025-10-06 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.